Torray Investment Partners LLC Grows Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Torray Investment Partners LLC raised its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 0.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 16,190 shares of the medical device company’s stock after buying an additional 132 shares during the period. Torray Investment Partners LLC’s holdings in Cooper Companies were worth $1,488,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Fulton Bank N.A. increased its holdings in Cooper Companies by 3.0% during the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock valued at $342,000 after buying an additional 109 shares during the last quarter. Mather Group LLC. increased its stake in shares of Cooper Companies by 7.4% in the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock worth $177,000 after purchasing an additional 133 shares in the last quarter. MassMutual Private Wealth & Trust FSB increased its stake in shares of Cooper Companies by 15.6% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock worth $93,000 after purchasing an additional 136 shares in the last quarter. Greenleaf Trust increased its stake in shares of Cooper Companies by 5.0% in the fourth quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock worth $268,000 after purchasing an additional 139 shares in the last quarter. Finally, UMB Bank n.a. increased its stake in shares of Cooper Companies by 22.5% in the fourth quarter. UMB Bank n.a. now owns 773 shares of the medical device company’s stock worth $71,000 after purchasing an additional 142 shares in the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the stock. StockNews.com cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Wells Fargo & Company increased their price objective on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th. Citigroup reduced their price objective on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research note on Friday, December 6th. Morgan Stanley dropped their target price on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research report on Friday, December 6th. Finally, Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat, Cooper Companies currently has an average rating of “Moderate Buy” and an average target price of $117.22.

Cooper Companies Trading Up 1.4 %

Shares of COO opened at $91.65 on Tuesday. The Cooper Companies, Inc. has a twelve month low of $84.76 and a twelve month high of $112.38. The company has a market cap of $18.29 billion, a P/E ratio of 47.00, a P/E/G ratio of 2.25 and a beta of 1.00. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The company’s fifty day simple moving average is $92.63 and its 200-day simple moving average is $99.59.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.03 billion. During the same quarter in the prior year, the firm posted $0.87 earnings per share. The business’s revenue for the quarter was up 9.8% on a year-over-year basis. As a group, analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.